Evidence map›Paper›PMID 24533274›Full record

ReviewInternational journal for parasitology. Drugs and drug resistance2012

Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present.

Carol Hopkins Sibley, Ric N Price

Open access · goldAbstract readReview
In one paragraph

Review in International journal for parasitology. Drugs and drug resistance, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Antimicrobial agents and chemotherapy · 2024
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  8. Article
  9. Article
  10. Antimicrobial activity of oleanolic and ursolic acids: an update.Evidence-based complementary and alternative medicine : eCAM · 2015
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Carol Hopkins SibleyWorldWide Antimalarial Resistance Network, Box 355065, University of Washington, Seattle, WA 98195 5065, USA.
Ric N PriceGlobal Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia ; Center for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom.
Charles Darwin University · AUUniversity of Washington · US

Funding

Wellcome Trust 091625
6 · The paper itself

Abstract

The need for robust surveillance of antimalarial drugs is more urgent than it has ever been. In the western region of Cambodia, artemisinin resistance has emerged in Plasmodium falciparum and threatens to undermine the efficacy of highly effective artemisinin combination therapies. Although some manfestations of artemisinin tolerance are unique to this class of drug, many of its properties mirror previous experience in understanding and tracking resistance to other antimalarials. In this review we outline the spectrum of approaches that were developed to understand the evolution and spread of antifolate resistance, highlighting the importance of integrating information from different methodologies towards a better understanding of the underlying biologic processes. We consider how to apply our experience in investigating and attempting to contain antifolate resistance to inform our prospective assessment of novel antimalarial resistance patterns and their subsequent spread.

Indexed as

ArtemisininDrug resistanceMalariaSurveillance

Identifiers

PMID24533274
PMCPMC3862427
OpenAlexW2110711164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.